Definition and quality requirements for stereotactic radiotherapy
Standard
Definition and quality requirements for stereotactic radiotherapy : consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery. / Guckenberger, Matthias; Baus, Wolfgang W; Blanck, Oliver; Combs, Stephanie E; Debus, Jürgen; Engenhart-Cabillic, Rita; Gauer, Tobias; Grosu, Anca L; Schmitt, Daniela; Tanadini-Lang, Stephanie; Moustakis, Christos.
In: STRAHLENTHER ONKOL, Vol. 196, No. 5, 05.2020, p. 417-420.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Definition and quality requirements for stereotactic radiotherapy
T2 - consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
AU - Guckenberger, Matthias
AU - Baus, Wolfgang W
AU - Blanck, Oliver
AU - Combs, Stephanie E
AU - Debus, Jürgen
AU - Engenhart-Cabillic, Rita
AU - Gauer, Tobias
AU - Grosu, Anca L
AU - Schmitt, Daniela
AU - Tanadini-Lang, Stephanie
AU - Moustakis, Christos
PY - 2020/5
Y1 - 2020/5
N2 - Stereotactic radiotherapy with its forms of intracranial stereotactic radiosurgery (SRS), intracranial fractionated stereotactic radiotherapy (FSRT) and stereotactic body radiotherapy (SBRT) is today a guideline-recommended treatment for malignant or benign tumors as well as neurological or vascular functional disorders. The working groups for radiosurgery and stereotactic radiotherapy of the German Society for Radiation Oncology (DEGRO) and for physics and technology in stereotactic radiotherapy of the German Society for Medical Physics (DGMP) have established a consensus statement about the definition and minimal quality requirements for stereotactic radiotherapy to achieve best clinical outcome and treatment quality in the implementation into routine clinical practice.
AB - Stereotactic radiotherapy with its forms of intracranial stereotactic radiosurgery (SRS), intracranial fractionated stereotactic radiotherapy (FSRT) and stereotactic body radiotherapy (SBRT) is today a guideline-recommended treatment for malignant or benign tumors as well as neurological or vascular functional disorders. The working groups for radiosurgery and stereotactic radiotherapy of the German Society for Radiation Oncology (DEGRO) and for physics and technology in stereotactic radiotherapy of the German Society for Medical Physics (DGMP) have established a consensus statement about the definition and minimal quality requirements for stereotactic radiotherapy to achieve best clinical outcome and treatment quality in the implementation into routine clinical practice.
U2 - 10.1007/s00066-020-01603-1
DO - 10.1007/s00066-020-01603-1
M3 - SCORING: Review article
C2 - 32211940
VL - 196
SP - 417
EP - 420
JO - STRAHLENTHER ONKOL
JF - STRAHLENTHER ONKOL
SN - 0179-7158
IS - 5
ER -